Home › Overweight › Texas
Overweight clinical trials in Texas
57 studies for Overweight are looking for participants at sites in Texas.
Cities in Texas
- San Antonio34 studies
- Houston33 studies
- Dallas23 studies
- Austin19 studies
- The Woodlands10 studies
- Grand Prairie10 studies
- Pharr9 studies
- Sugar Land8 studies
- El Paso6 studies
- Fort Worth6 studies
- Mesquite6 studies
- Brownsville6 studies
- Corpus Christi5 studies
- Amarillo4 studies
- Tyler4 studies
- Denison3 studies
- Garland3 studies
- Round Rock3 studies
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
- Cedar Health Research- Texas Native Health, Dallas
- Cedar Health Research, LLC, Dallas
- Soma Clinical Trials, LLC, Denison
- and 5 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 9, 2026 · NCT07871409A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Bellaire Clinical Research, LLC, Bellaire
- South Texas Research Institute - Brownsville, Brownsville
- South Texas Clinical Research, Corpus Christi
- and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351045A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Headlands Research Brownsville, Brownsville
- Velocity Clinical Research, Dallas
- South Texas Research Institute - Edinburg, Edinburg
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07351058Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Pinnacle Clinical Research Georgetown, Austin
- Epic Medical Research - DeSoto, DeSoto
- Biopharma Informatic, LLC, Houston
- and 8 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT07575399A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Velocity Clinical Research, Dallas, Dallas
- DM Clinical Research, Tomball
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07823608A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
- Mercy Family Clinic, Dallas
- Cedar Health Research, Fort Worth
- JCCT-JUNO NW Houston, Houston
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07919678A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- IMA Clinical Research Austin, Austin
- Headlands Horizons, LLC dba Headlands Research-Brownsville, Brownsville
- Cedar Health Research - Texas Native Health, Dallas
- and 10 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- PlanIt Research, LLC (Monitoring Room), Houston
- PlanIt Research, LLC, Houston
- VIP Trials, San Antonio
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Diabetes and Thyroid Center of Ft. Worth, Fort Worth
- Juno Research, Houston
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07881458A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Bellaire Dermatology Associates, Bellaire
- Modern Research Associates, PLLC, Dallas
- Center for Clinical Studies, Houston
- and 3 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06857942A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- IMA Clinical Research Austin, Austin
- Private Practice - Dr. Osvaldo A. Brusco, Corpus Christi
- Velocity Clinical Research, Dallas, Dallas
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- UT Southwestern Medical Center, Dallas
- Juno Research, Houston
- Activian Clinical Research, Kingwood
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- JCCT - Juno Bellaire Site, Bellaire
- Epic Medical Research - DeSoto, DeSoto
- Valley Institute of Research - Fort Worth, Fort Worth
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937099A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- FutureSearch Trials of Neurology, Austin
- Sleep Therapy Research Center, San Antonio
- Consano Clinical Research, LLC, Shavano Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07369011Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Nov 4, 2026 · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Dell Children's Medical Center - PIN, Austin
- Driscoll Children's Hospital, Corpus Christi
- McGovern Medical School, Houston
- and 4 more
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Nov 4, 2026 · NCT06672549A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Juno Research, Houston
- Southern Endocrinology Associates, Mesquite
- Texas Diabetes & Endocrinology, P.A., Round Rock
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Nov 4, 2026 · NCT06897475Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- Fortrea Clinical Research Unit - Dallas, Dallas
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Nov 2, 2026 · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Houston
- Research Site, San Antonio
- Research Site, Sugar Land
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07784725A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, DeSoto
- Research Site, El Paso
- Research Site, Houston
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07784270Healthy Living BEYOND Weight Study
- American Heart Association, Dallas
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07075341Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Amarillo Medical Specialists /ID# 282380, Amarillo
- Elligo Clinical Research Center /ID# 282166, Austin
- JCCT - Juno Bellaire /ID# 282263, Bellaire
- and 6 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 27, 2026 · NCT07752979Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- DM Clinical Research, Irving
- DM Clinical Research - Dominion Family Healthcare, San Antonio
- Tekton Research, San Antonio
- and 1 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 26, 2026 · NCT07837973Improving Glycemic Control With Electrical Stimulation
- University of Texas at El Paso, El Paso
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT03947697A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Austin
- ACCOMPLISH-2 Research Site, Farmers Branch
- ACCOMPLISH-2 Research Site, Houston
- and 4 more
RecruitingPhase 3Healthy volunteers welcome
Ages 18 to 79 · All sexes · Updated Oct 20, 2026 · NCT07654374PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study
- UT MD Anderson, Houston
RecruitingPhase 2
Ages 18 to 39 · All sexes · Updated Oct 20, 2026 · NCT07874828Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events
- Amarillo Medical Specialists, Amarillo
- Elligo Clin Res Centre, Austin
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT07607587Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Baylor College of Medicine, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT06273072A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- ICON Early Phase Services, LLC, San Antonio
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 15, 2026 · NCT07654972A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy
- Fortrea Clinical Research Unit, Dallas
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 65 · All sexes · Updated Oct 8, 2026 · NCT07808073A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- IMA Clinical Research Austin, Austin
- FutureSearch Trials of Dallas, Dallas
- PlanIt Research, PLLC, Houston
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 8, 2026 · NCT07589608A Study of Eloralintide (LY3841136) in Female Participants With Obesity or Overweight
- Fortrea Clinical Research Unit, Dallas
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 60 · Women · Updated Oct 8, 2026 · NCT07808060A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- IMA Clinical Research Austin, Austin
- Velocity Clinical Research, Dallas, Dallas
- FutureSearch Trials of Dallas, Dallas
- and 3 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 7, 2026 · NCT06143956AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Epic Medical Research, DeSoto
- Advanced Neurology Epilepsy and Sleep Center ANESC, El Paso
- Biorhythms Center for Integrative Sleep Medicine, El Paso
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT07571109Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Elligo Clinical Research Center, Austin
- Johnson County Clinical Trials Juno Bellaire, Bellaire
- Cedar Health Research, LLC, Dallas
- and 8 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Elligo Clinical Research Center, Austin
- Johnson County Clinical Trials Juno Bellaire, Bellaire
- Osvaldo A Brusco MD PA, Corpus Christi
- and 1 more
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Oct 5, 2026 · NCT07684144A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
- Kailera Clinical Site, San Antonio
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 85 · All sexes · Updated Oct 1, 2026 · NCT07793929A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- DM Clinical, Houston
- DM Clinical, San Antonio
- The Texas Liver Institute, San Antonio
- and 3 more
RecruitingPhase 3
Ages 8 to 18 · All sexes · Updated Sep 30, 2026 · NCT07253285From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.